Chikashi Ishioka

22PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer geneticsHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling Pathway.

|Aug 14, 2025
Plasma Lysophosphatidylcholine Levels Correlate with Prognosis and Immunotherapy Response in Squamous Cell Carcinoma.

Tomoyuki Iwasaki, Hidekazu Shirota, Eiji Hishinuma

|Jun 26, 2025
Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer.

Reio Ueta, Hiroo Imai, Ken Saijo

|Apr 18, 2025
Regional Differences in the Frequency of BRCA1 and BRCA2 Variants in Northeastern Japan: A Cohort Study.

Hidekazu Shirota, Akimitsu Miyake, Maako Kawamura

|Sep 26, 2024
Specific cancer types and prognosis in patients with variations in the KEAP1-NRF2 system: A retrospective cohort study.

Tomoyuki Iwasaki, Hidekazu Shirota, Keiju Sasaki

|Aug 23, 2024
Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in BRAFV600E colorectal cancer.

Yuya Yoshida, Masanobu Takahashi, Sakura Taniguchi

Pageof 4

Frequent Collaborators

6 joint publications

Ken Saijo

5 joint publications

Shin Takahashi

5 joint publications

Kota Ouchi

5 joint publications

Hidekazu Shirota